Oversewing versus surgical ligation clips to reinforce the gastric pouch after one-anastomosis gastric bypass

A Comparative Study to Evaluate Efficacy of Oversewing Versus Surgical Ligation Clips for Staple Line Reinforcement of the Gastric Pouch to Reduce Post Operative Bleeding in Laparoscopic One Anastomosis Gastric Bypass

Not applicable Interventional Cairo University · NCT07238309

This trial will test whether oversewing or surgical clips better reduce bleeding and the need for blood transfusions after laparoscopic one-anastomosis gastric bypass in adults.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment30 (estimated)
Ages18 Years to 80 Years
SexAll
SponsorCairo University Academic / other
Locations1 site (Cairo, Cairo Governorate)
Trial IDNCT07238309 on ClinicalTrials.gov

What this trial studies

This randomized interventional comparison at the Faculty of Medicine, Cairo University enrolls adults undergoing laparoscopic one-anastomosis gastric bypass (OAGB) and assigns them to either oversewing or surgical ligation clips for staple-line reinforcement of the gastric pouch. Participants are followed for postoperative staple-line bleeding, need for blood transfusion, operative time, and cost outcomes. The primary outcomes are rates of postoperative bleeding and transfusion requirement, with secondary outcomes including operative duration and a cost analysis. Key exclusions include bleeding disorders, pregnancy or breastfeeding, and refusal of consent.

Who should consider this trial

Good fit: Adults aged 18 or older who are fit for bariatric surgery with BMI ≥40 kg/m2 or BMI 35–40 kg/m2 with significant comorbidities and who have tried non-surgical weight-loss measures for at least six months and can provide informed consent.

Not a fit: Patients with known bleeding disorders, pregnant or breastfeeding women, those requiring re-exploration for bleeding not related to the staple line, or anyone not undergoing OAGB are unlikely to benefit from this comparison.

Why it matters

Potential benefit: If successful, this could lower postoperative bleeding and transfusion rates after OAGB, shorten operating time, and reduce procedural costs, improving patient safety and recovery.

How similar studies have performed: Staple-line reinforcement methods have been compared in other bariatric procedures with mixed results, and direct high-quality evidence specifically comparing oversewing versus clips for OAGB is limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ✔ Age ≥ 18years old

  * Sex: both sex
  * Fit for bariatric surgery
  * body mass index (BMI) of 40 kg/m 2 or higher or BMI between 35 and 40 kg/m2 with significant comorbidities, such as T2DM, hypertension, OSAS or significant osteo- articular alterations, not responsive to medical therapies
  * Patients should have tried and failed to lose weight using diet, exercise, and/or medication for at least 6 months
  * Patients or first guardians accept to participate in the current study
  * Patients or first guardians accept to provide informed written consent

Exclusion Criteria:

* Patients less than 18 years old

  * Patients or first guardians refused to participate in the current study
  * Patients or first guardians refused to provide informed written consent
  * All patients with bleeding disorders and patients needing re-exploration for bleeding other than staple line Pregnant or breastfeeding women

Where this trial is running

Cairo, Cairo Governorate

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Gastric Bypass SurgeryLaparoscopic One Anastomosis Gastric Bypass surgery
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.